NUZ 6.25% 22.5¢ neurizon therapeutics limited

Bioshares Number 697 - 26 May 2017

  1. 478 Posts.
    lightbulb Created with Sketch. 765
    The essential Australian Biotech Investment Event

    Pharm Aust Limited has made a number of very substantial announcements in the past few months. I feel sure that there will be many more to follow. Judging by the last one, it has become crystal clear now, that our CEO and EC, are going to turn Pharm Aust Limited into a global company.

    I believe Pharm Aust Limited may be featuring at the 2017 Biotech Summit, to be held in Queenstown New Zealand?

    Everything is coming together, from my understanding on all fronts and what better way to gain GLOBAL exposure.

    Bioshares recommendation : Speculative Hold Class B

    This may well be the launching pad that we have all been waiting for as shareholders...

    As always,

    All the best
    MM
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.